BBNX

Beta Bionics Inc

Apr 09 • 04:00PM ET

9.63

-0.16 -1.63 %

Healthcare • Medical Devices • USA • NASD

Held by: VTI IWM VXF IWO VTWO SCHA IHI XHE ITOT SNSR

Index	RUT	P/E	-	EPS (ttm)	-1.68	Insider Own	22.22%	Shs Outstand	44.36M	Perf Week	-3.80%
Market Cap	427.40M	Forward P/E	-	EPS next Y	-2.00	Insider Trans	-0.54%	Shs Float	34.52M	Perf Month	-12.22%
Enterprise Value	215.48M	PEG	-	EPS next Q	-0.50	Inst Own	96.98%	Short Float	20.29%	Perf Quarter	-69.42%
Income	-73.20M	P/S	4.26	EPS this Y	-9.09%	Inst Trans	-0.08%	Short Ratio	5.38	Perf Half Y	-56.52%
Sales	100.25M	P/B	1.49	EPS next Y	-1.43%	ROA	-30.60%	Short Interest	7.01M	Perf YTD	-68.40%
Book/sh	6.48	P/C	1.95	EPS next 5Y	7.91%	ROE	-40.26%	52W High	32.71 -70.56%	Perf Year	-18.46%
Cash/sh	4.94	P/FCF	-	EPS past 3/5Y	-6.13% -	ROIC	-24.99%	52W Low	9.37 2.77%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	724.29% -	Gross Margin	55.40%	Volatility	5.77% 6.32%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.15	EPS Y/Y TTM	-32.69%	Oper. Margin	-71.50%	ATR (14)	0.73	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.96	Sales Y/Y TTM	53.94%	Profit Margin	-73.02%	RSI (14)	30.42	Recom	1.55
Dividend Gr. 3/5Y	- -	Current Ratio	8.66	EPS Q/Q	27.05%	SMA20	-7.81%	Beta	4.73	Target Price	23.09
Payout	-	Debt/Eq	0.03	Sales Q/Q	57.15%	SMA50	-19.95%	Rel Volume	0.64	Prev Close	9.79
Employees	423	LT Debt/Eq	0.02	Earnings	Apr 21 AMC	SMA200	-50.23%	Avg Volume	1.30M	Price	9.63
IPO	Jan 30, 2025	Option/Short	Yes / Yes	EPS/Sales Surpr.	25.60% 5.69%	Trades		Volume	829,519	Change	-1.63%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-09-26	Initiated	UBS	Buy	$24
Jan-27-26	Initiated	TD Cowen	Hold	$17
Jan-09-26	Downgrade	BofA Securities	Buy → Neutral
Oct-21-25	Resumed	Stifel	Buy	$26
Oct-01-25	Upgrade	Goldman	Neutral → Buy	$26
Jun-16-25	Initiated	Truist	Buy	$26
Jun-12-25	Initiated	Lake Street	Buy	$30
May-30-25	Initiated	Wolfe Research	Outperform	$20
May-30-25	Initiated	Goldman	Neutral	$16
Feb-24-25	Initiated	Stifel	Buy	$25
Feb-24-25	Initiated	Piper Sandler	Overweight	$26
Feb-24-25	Initiated	Leerink Partners	Outperform	$28
Feb-24-25	Initiated	Lake Street	Buy	$30
Feb-24-25	Initiated	BofA Securities	Buy
Feb-20-25	Initiated	Robert W. Baird	Neutral	$20
Feb-20-25	Initiated	Ladenburg Thalmann	Neutral	$20

Show Previous Ratings

Mar-31-26 06:00AM	Beta Bionics Introduces Bionic Insights in Bionic Reports - Transforming How Clinicians Understand and Optimize Diabetes Care (GlobeNewswire)
Mar-30-26 04:11PM	Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026 (GlobeNewswire) -8.36%
Mar-06-26 04:50AM	Beta Bionics Details iLet Automation Strategy, Sales Expansion and Mint Patch Pump Timeline at Conference (MarketBeat)
Feb-20-26 05:00AM	Senseonics launches automated insulin dosing system with 1-year CGM (MedTech Dive)
Feb-19-26 04:05PM	Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
08:30AM	Loading…
Feb-18-26 08:30AM	Beta Bionics, Inc. Q4 2025 Earnings Call Summary (Moby)
12:01AM	Beta Bionics Inc (BBNX) Q4 2025 Earnings Call Highlights: Record Growth Amid Regulatory Challenges (GuruFocus.com)
Feb-17-26 07:00PM	Beta Bionics Q4 Earnings Call Highlights (MarketBeat)
05:25PM	Beta Bionics, Inc. (BBNX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 (GlobeNewswire)
Feb-16-26 07:20AM	Earnings To Watch: Beta Bionics Inc (BBNX) Reports Q4 2025 Result (GuruFocus.com)
Feb-10-26 10:00AM	Will Beta Bionics, Inc. (BBNX) Report Negative Earnings Next Week? What You Should Know (Zacks) +6.56%
Feb-09-26 09:36AM	Oracle gets upgrade and downgrade: Wall Street's top analyst calls (The Fly) +6.04%
Feb-02-26 09:21AM	Beta Bionics receives FDA warning letter (MedTech Dive)
Jan-15-26 04:03PM	Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 (GlobeNewswire)
12:02PM	Loading…
Jan-09-26 12:02PM	Beta Bionics Key KPI Miss Targets, Analyst Flags Valuation Risks (Benzinga) -37.04%
Jan-08-26 04:04PM	Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics (GlobeNewswire)
Dec-09-25 07:10AM	Medline seeks $5.37bn in largest healthcare IPO of 2025 (Medical Device Network)
Dec-08-25 07:45AM	Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 (GlobeNewswire)
Nov-03-25 04:08PM	Beta Bionics Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Oct-30-25 03:25PM	Beta Bionics Inc (BBNX) Q3 2025 Earnings Call Highlights: Record Growth and Strategic Challenges (GuruFocus.com)
Oct-28-25 06:30PM	Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +10.34%
04:02PM	Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance (GlobeNewswire)
Oct-27-25 09:38AM	What to Expect from Beta Bionics Inc (BBNX) Q3 2025 Earnings (GuruFocus.com) +13.37%
Oct-16-25 04:33PM	Goldman Sachs Upgrades Beta Bionics (BBNX) to Buy, Raises PT to $26 on Strong Growth and Market Outlook (Insider Monkey)
Oct-09-25 08:00AM	Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025 (GlobeNewswire)
Aug-21-25 08:00AM	Beta Bionics Announces Participation at Upcoming Investor Conferences (GlobeNewswire) +10.39%
Jul-30-25 03:17AM	Beta Bionics Inc (BBNX) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com) +14.32%
Jul-29-25 04:02PM	Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance (GlobeNewswire)
03:20PM	Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival (Bloomberg)
02:43AM	Loading…
Jul-04-25 02:43AM	Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas (Insider Monkey)
Jul-02-25 07:30AM	Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 (GlobeNewswire)
Jun-24-25 03:59PM	Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions (GlobeNewswire)
06:56AM	ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors (MedTech Dive)
Jun-23-25 11:20AM	BBNX Stock May Gain From Abbott Deal to Advance iLet Integration (Zacks) -11.68%
Jun-20-25 07:06AM	5 things to watch at the ADAs Scientific Sessions (MedTech Dive)
Jun-19-25 07:00AM	Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor (GlobeNewswire)
Jun-16-25 10:21AM	Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth (Investing.com)
Jun-02-25 05:01AM	Beta Bionics CEO, CFO on how to take a company public (MedTech Dive) +8.41%
May-29-25 05:44AM	The medtech IPO window is finally open. Or is it? (MedTech Dive) +6.44%
May-07-25 03:22AM	Beta Bionics Inc (BBNX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com) +26.61%
May-06-25 04:02PM	Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 (GlobeNewswire)
May-01-25 08:00AM	Beta Bionics to Present at the Bank of America Securities Health Care Conference (GlobeNewswire)
Apr-24-25 11:44AM	Beta Bionics: Slowing Down Or Being Conservative? (Seeking Alpha) +5.74%
Apr-19-25 05:30AM	ClearBridge Small Cap Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-16-25 04:05PM	Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 (GlobeNewswire)
Apr-09-25 07:30AM	Beta Bionics to Host Investor Event on June 22, 2025 (GlobeNewswire) +21.63%
Mar-28-25 06:00AM	Newly public Beta Bionics reports sales surge; Dexcom hires CCO (MedTech Dive) -7.58%
Mar-27-25 04:45PM	Beta Bionics Announces Board Appointment of Gerard Michel (GlobeNewswire)
Mar-25-25 04:02PM	Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 (GlobeNewswire) -13.60%
Mar-03-25 12:59PM	Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently (Insider Monkey)
Feb-27-25 07:00AM	Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 (GlobeNewswire)
Feb-21-25 09:35AM	Palantir initiated, Roku upgraded: Wall Streets top analyst calls (TipRanks)
Jan-31-25 05:56PM	Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
06:34AM	Beta Bionics raises $204M in IPO (MedTech Dive)
Jan-30-25 12:55PM	Beta Bionics raises $204m to kickstart medtech IPO season (Medical Device Network)
Jan-29-25 10:34PM	Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering (GlobeNewswire)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hopman Mark	Chief Commercial Officer	Dec 04 '25	Sale	30.66	2,061	63,192	136,216	Mar 16 07:55 PM
Hopman Mark	Chief Commercial Officer	Dec 02 '25	Sale	29.34	856	25,112	138,277	Mar 16 07:55 PM
Russell Steven Jon	Chief Medical Officer	Dec 02 '25	Sale	29.34	1,025	30,069	178,071	Mar 16 07:55 PM
Hopman Mark	Chief Commercial Officer	Mar 04 '26	Sale	11.57	353	4,084	139,133	Mar 05 07:30 PM
Mark Hopman	Officer	Mar 04 '26	Proposed Sale	11.57	353	4,084		Mar 04 06:02 PM
Michael R. Mensinger	Officer	Mar 02 '26	Proposed Sale	12.52	1,064	13,321		Mar 04 04:58 PM
Stephen Feider	Officer	Mar 02 '26	Proposed Sale	12.52	1,428	17,879		Mar 04 04:56 PM
Sean Saint	Officer	Mar 02 '26	Proposed Sale	12.52	3,384	42,368		Mar 04 04:54 PM
Hopman Mark	Chief Commercial Officer	Mar 02 '26	Sale	12.36	834	10,310	139,486	Mar 03 06:45 PM
Russell Steven Jon	Chief Medical Officer	Mar 02 '26	Sale	12.36	1,026	12,683	179,096	Mar 03 06:45 PM
Mensinger Mike	Chief Product Officer	Mar 02 '26	Sale	12.36	1,064	13,153	188,793	Mar 03 06:45 PM
Feider Stephen	Chief Financial Officer	Mar 02 '26	Sale	12.36	1,428	17,652	172,729	Mar 03 06:45 PM
Saint Sean	President & CEO	Mar 02 '26	Sale	12.36	3,384	41,832	437,809	Mar 03 06:45 PM
Mensinger Mike	Chief Product Officer	Jan 06 '26	Sale	30.10	2,200	66,221	80,752	Jan 07 04:16 PM
Mensinger Mike	Chief Product Officer	Jan 02 '26	Sale	29.61	7,800	230,950	82,952	Jan 05 06:05 PM
Feider Stephen	Chief Financial Officer	Jan 02 '26	Option Exercise	5.10	20,000	102,000	62,614	Jan 05 06:03 PM
Feider Stephen	Chief Financial Officer	Jan 02 '26	Sale	29.53	20,000	590,680	42,614	Jan 05 06:03 PM
MICHAEL MENSINGER	Officer	Jan 02 '26	Proposed Sale	30.47	10,000	304,700		Jan 02 04:27 PM
Stephen Feider	Officer	Jan 02 '26	Proposed Sale	29.53	20,000	590,680		Jan 02 04:17 PM
Mark Hopman	Officer	Dec 04 '25	Proposed Sale	30.66	2,061	63,192		Dec 04 04:41 PM
Mensinger Mike	Chief Product Officer	Dec 02 '25	Sale	29.34	1,063	31,184	90,752	Dec 04 04:20 PM
Feider Stephen	Chief Financial Officer	Dec 02 '25	Sale	29.34	1,427	41,862	42,614	Dec 04 04:20 PM
Saint Sean	President & CEO	Dec 02 '25	Sale	29.34	3,278	96,163	97,924	Dec 04 04:20 PM
Sean Saint	Officer	Dec 02 '25	Proposed Sale	29.34	3,278	96,163		Dec 04 04:14 PM
Michael R. Mensinger	Officer	Dec 02 '25	Proposed Sale	29.34	1,063	31,184		Dec 04 04:12 PM
Stephen Feider	Officer	Dec 02 '25	Proposed Sale	29.34	1,427	41,862		Dec 04 04:11 PM
Lezack Adam	Director	Dec 01 '25	Sale	29.55	1,406	41,543	8,435	Dec 02 04:20 PM
Palasis Maria	Director	Dec 01 '25	Sale	29.55	1,406	41,552	8,435	Dec 02 04:20 PM
Lezack Adam	Director	Oct 31 '25	Sale	26.87	1,406	37,780	9,841	Nov 05 09:45 PM
Palasis Maria	Director	Oct 31 '25	Sale	26.91	1,406	37,834	9,841	Nov 05 09:45 PM
ADAM LEZACK	Director	Oct 31 '25	Proposed Sale	26.78	2,812	75,305		Oct 31 04:14 PM
MARIA PALASIS	Director	Oct 31 '25	Proposed Sale	26.78	2,812	75,305		Oct 31 04:13 PM
Feider Stephen	Chief Financial Officer	Oct 03 '25	Option Exercise	5.10	4,982	25,408	49,023	Oct 07 04:15 PM
Feider Stephen	Chief Financial Officer	Oct 03 '25	Sale	21.69	4,982	108,076	44,041	Oct 07 04:15 PM
Feider Stephen	Chief Financial Officer	Oct 01 '25	Option Exercise	5.10	15,018	76,592	59,059	Oct 03 04:31 PM
Feider Stephen	Chief Financial Officer	Oct 01 '25	Sale	20.76	15,018	311,806	44,041	Oct 03 04:31 PM
Stephen Feider	Officer	Oct 03 '25	Proposed Sale	21.69	4,982	108,076		Oct 03 03:34 PM
Stephen Feider	Officer	Oct 01 '25	Proposed Sale	20.76	15,018	311,837		Oct 01 04:42 PM
Feider Stephen	Chief Financial Officer	Sep 08 '25	Option Exercise	5.10	9,900	50,490	53,941	Sep 09 04:12 PM
Feider Stephen	Chief Financial Officer	Sep 08 '25	Sale	21.13	9,900	209,151	44,041	Sep 09 04:12 PM
Hopman Mark	Chief Commercial Officer	Sep 05 '25	Option Exercise	5.10	11,411	58,196	42,626	Sep 08 06:15 PM
Hopman Mark	Chief Commercial Officer	Sep 04 '25	Option Exercise	5.10	4,749	24,220	38,033	Sep 08 06:15 PM
Hopman Mark	Chief Commercial Officer	Sep 05 '25	Sale	20.56	11,411	234,657	31,215	Sep 08 06:15 PM
Hopman Mark	Chief Commercial Officer	Sep 04 '25	Sale	19.97	6,818	136,180	31,215	Sep 08 06:15 PM
Feider Stephen	Chief Financial Officer	Sep 05 '25	Option Exercise	5.10	100	510	44,141	Sep 08 06:15 PM
Feider Stephen	Chief Financial Officer	Sep 05 '25	Sale	21.00	100	2,100	44,041	Sep 08 06:15 PM
Feider Stephen	Officer	Sep 08 '25	Proposed Sale	21.13	9,900	209,152		Sep 08 02:23 PM
Hopman Mark	Officer	Sep 05 '25	Proposed Sale	20.56	11,411	234,657		Sep 05 05:24 PM
Feider Stephen	Officer	Sep 05 '25	Proposed Sale	21.00	100	2,100		Sep 05 05:12 PM
Saint Sean	President & CEO	Sep 02 '25	Sale	18.86	3,359	63,361	101,202	Sep 04 06:45 PM
Russell Steven Jon	Chief Medical Officer	Sep 02 '25	Sale	18.86	1,015	19,146	71,017	Sep 04 06:45 PM
Mensinger Mike	Chief Product Officer	Sep 02 '25	Sale	18.86	1,089	20,542	91,815	Sep 04 06:45 PM
Hopman Mark	Chief Commercial Officer	Sep 02 '25	Sale	18.86	848	15,996	33,284	Sep 04 06:45 PM
Feider Stephen	Chief Financial Officer	Sep 02 '25	Sale	18.86	1,462	27,578	44,041	Sep 04 06:45 PM
Hopman Mark	Officer	Sep 04 '25	Proposed Sale	19.97	6,818	136,180		Sep 04 04:33 PM
Feider Stephen	Chief Financial Officer	Aug 22 '25	Option Exercise	5.10	4,413	22,506	49,916	Aug 26 04:29 PM
Feider Stephen	Chief Financial Officer	Aug 22 '25	Sale	17.01	4,413	75,083	45,503	Aug 26 04:29 PM
Feider Stephen	Officer	Aug 22 '25	Proposed Sale	17.01	4,413	75,083		Aug 22 11:10 AM
Hopman Mark	Chief Commercial Officer	Aug 19 '25	Option Exercise	5.10	16,158	82,406	50,290	Aug 20 09:30 PM
Hopman Mark	Chief Commercial Officer	Aug 19 '25	Sale	16.61	16,158	268,376	34,132	Aug 20 09:30 PM
Feider Stephen	Chief Financial Officer	Aug 19 '25	Option Exercise	5.10	5,587	28,494	51,090	Aug 20 09:30 PM
Feider Stephen	Chief Financial Officer	Aug 19 '25	Sale	17.03	5,587	95,172	45,503	Aug 20 09:30 PM
Feider Stephen	Officer	Aug 19 '25	Proposed Sale	17.03	5,587	95,172		Aug 19 05:41 PM
Hopman Mark	Officer	Aug 19 '25	Proposed Sale	16.61	16,158	268,376		Aug 19 05:30 PM
Sean Saint	Officer	Jun 02 '25	Proposed Sale	17.89	3,439	61,524		Jun 09 08:30 PM
Hopman Mark	Chief Commercial Officer	Jun 02 '25	Sale	17.89	868	15,529	34,132	Jun 04 07:30 PM
Russell Steven Jon	Chief Medical Officer	Jun 02 '25	Sale	17.89	1,039	18,588	72,032	Jun 04 07:30 PM
Mensinger Mike	Chief Product Officer	Jun 02 '25	Sale	17.89	1,115	19,948	92,904	Jun 04 07:30 PM
Feider Stephen	Chief Financial Officer	Jun 02 '25	Sale	17.89	1,497	26,783	45,503	Jun 04 07:30 PM
Saint Sean	President & CEO	Jun 02 '25	Sale	17.89	3,439	61,526	104,561	Jun 04 07:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BBNX

Beta Bionics Inc

Upgrade your Finviz experience